C2N Diagnostics
Highly Engaged Employees
Business Services · Missouri, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4340 Duncan Ave, Saint Louis, Missouri, ...Phone Number
(877) 226-3424Website
www.c2n.comRevenue
<$5 MillionIndustry
About C2N Diagnostics
C2N Diagnostics is a specialty diagnostics company focused on developing and commercializing innovative blood tests for Alzheimer's disease and related neurodegenerative conditions. Their flagship products, the PrecivityAD and PrecivityAD2 tests, utilize advanced mass spectrometry techniques to assess brain amyloid pathology, aiding healthcare professionals in diagnosing and managing cognitive impairment. Targeted at patients aged 50 and older, these tests are designed to enhance clinical decision-making and improve patient care. C2N Diagnostics aims to maximize the efficiency of clinical trials and support healthcare researchers in understanding disease mechanisms and identifying new treatment targets.Explore more
SIC Code 87,873NAICS Code 54,541Show moreC2N Diagnostics Org Chart
Compare Similar Companies to C2N Diagnostics
Compare insights from companies similar to C2N Diagnostics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
C2N Diagnostics
<$5M
11-50
Private
$40M
2007
MO
Micah OnixtExecutive Vice President & General Counsel & Privacy Officer & Corporate Secretary
C2N Diagnostics Tech Stack
A closer look at the technologies used by C2N Diagnostics
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding C2N Diagnostics
Sign Up For FreeTo access detailed company insights
C2N Diagnostics is a specialty diagnostics company focused on developing and commercializing innovative blood tests for Alzheimer's disease and related neurodegenerative conditions. Their flagship products, the PrecivityAD and PrecivityAD2 tests, utilize advanced mass spectrometry techniques to assess brain amyloid pathology, aiding healthcare prof... Read More